Citius Pharmaceuticals Soars 10.71% on Strategic Initiatives
Citius Pharmaceuticals (NASDAQ: CTXR) surged 10.71% in pre-market trading on September 1, 2025, marking a significant rise in its stock price.
Citius Pharmaceuticals has been in the spotlight recently due to various developments that have influenced its stock performance. The company's stock has been subject to market speculation and investor interest, driven by its strategic initiatives and market positioning.
Investors have been closely monitoring CitiusCTXR-- Pharmaceuticals' stock, with real-time bid and ask information powered by Nasdaq Basic. This data feed provides insights into the stock's liquidity and market dynamics, helping investors make informed trading decisions.

Get the scoop on pre-market movers and shakers in the US stock market.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet